Prostate Cancer Patients need earlier, safer & more effective therapy.

We are changing the conversation.

Developing gene-based, cost-effective Immunotherapies for men throughout the entire spectrum of prostate cancer progression: from premetastatic, to newly metastatic, to late stage metastatic disease.